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• From 1st January 2019 to 31st January 2020, 13 cryptomarkets were
monitored, and 7 cryptomarkets closed down.
• Dream Market was responsible for 80% of drug listings each week until
closure on the 30th April 2019.
• Cannabis, MDMA, cocaine, benzodiazepines and meth/amphetamine were
the five drugs accounting for the greatest percentage of listings (64%).
• The market share of cannabis declined from 32% in January 2019 to 27% in
January 2020.
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This bulletin series reports on trends in the availability and type of substances sold
on the internet via cryptomarkets over the last 12 months (new bulletin released
every four months). The current bulletin focuses on analysis of listings from 1st
January 2019 to 31st January 2020.
Drug Trends have identified, crawled (or ‘scraped’) , extracted, categorised and
analysed drug listings on cryptomarkets on a weekly basis since 1st January 2014,
formerly using VBA programming processes, and since 9th August 2018 using a
range of programmed automated processes in Python that operate with minimal
manual input. Further background and information regarding the methods are
available for download.
Our reporting focuses only on identified English-language cryptomarkets selling
drugs which have ≥100 drug listings and ≥1 vendor. For a historical record of
marketplaces monitored by DNeT, we refer the reader to our interactive timeline.
Analyses are concentrated on listings on these marketplaces advertising the sale
of illicit drugs (e.g., heroin), key licit drugs (e.g., alcohol, tobacco, e-cigarettes) and
pharmaceutical medicines, as well as drug-related paraphernalia (e.g., needles
and syringes, reagent test kits).
Following extraction of common text features across each listing (e.g., drug listing
name, vendor name and the price in bitcoin or dollars), individual listings are
categorised according to a pre-specified classification structure using a rules-
based approach through text-matching in the first instance, followed by a long
short-term memory (LSTM) artificial neural network (target predictive percentage
90%) that has been trained on historically categorised listings for those not
matched through the former process (see methods for full details).
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Cryptomarkets (‘darknet markets’) are anonymous online trading platforms
that facilitate the purchasing of illicit goods and services via multiple sellers.
Number of listings is the sum of listings per single scrape each week
belonging to a specific market or drug class. For this measure, duplicate listings
(defined as listings with identical names and same quantity of drug by a single
vendor on a single market) within the same week are removed.
Number of vendors is the sum of unique vendors per single scrape each week
selling a specific drug category. For this measure, a vendor is considered
unique only within the same market only; that is, the same vendor may be
counted multiple times across different markets.
An accompanying public online interactive data visualisation is available,
allowing viewers to interact with data collected over the total monitoring period.
Data presented here comprise number of listings and number of vendors observed
in a given week (see Panel A). These data can be considered reasonable
estimates for trends in drug availability, as we cannot guarantee immediate
identification and capture of cryptomarkets once they emerge. Further, data
provided here can only be used as a proxy of drug availability on cryptomarkets:
we have not translated to any metric that reflects the sale volume of a market or
specific drug. See here for further discussion of caveats to interpretation.
There are various approaches to collecting, collating, categorising and analysing
cryptomarket data, and inherent challenges in these processes. For this reason, we have
attempted to be as transparent as possible about our procedures. Our monitoring is an
ongoing process, requiring constant refinements to the various stages. We welcome
feedback and suggestions so that we can continue to improve utility of these data and our
reporting on them (drugtrends@unsw.edu.au ).
The current bulletin reports for the time period 1st January 2019 to 31st January
2020. In that period, 13 cryptomarkets were monitored (Figure 1). Of these, 7
markets were closed for the following purported reasons (internet sources
hyperlinked on market name):
• Wall Street – A German law enforcement operation resulted in the shutdown of
the market on 23rd April 2019.
• Dream Market – On 4th March 2019, Dream Market administers announced the
shutdown of the market on 30th April 2019. In this announcement, Dream Market
declared they would move services to a partner market, however the provided
onion URL to this marketplace was not operational. Due to a period of sustained
Distributed Denial of Service attacks (DDoS; in which multiple sources are used
to generate a large amount of traffic to an online service, thereby overwhelming
its servers), resulting in the inability to run relevant automatic scripts, Dream
Market was last monitored on 28th March 2019.
• Berlusconi – An Italian law enforcement operation resulted in the shutdown of
the market on 26th September 2019.
• Cryptonia Market – For reasons unknown to the authors, Cryptonia Market
ceased operations on 14th November 2019.
• Tochka – Due to an exit scam, Tochka shutdown on the 28th November 2019.
• CGMC – Due to market issues in undertaking withdrawals, CGMC ended
operations on 2nd May 2019.
• Apollon - Due to an exit scam, Apollon ended operations on 28th April 2019.
An additional market, Nightmare, was identified in this period but we were unable
to monitor manually or via establishing scripts for automated scripts. Nightmare
was closed on 26th July 2019 due to an exit scam.
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Note: See our interactive timeline for a complete historical record of all cryptomarkets monitored since
January 2014. Breaks indicate period where market crawling was not achievable. Width of bar is proportional
to log of average listings. The width of the bar is proportional to the log of the number of drug listings observed
in each week for each market.
The longest-established market in this monitoring period was Dream Market. Our
monitoring of Dream Market commenced in November 2014. Over the total
monitoring period of the market, it has had the greatest number of listings and
number of vendors of all markets monitored until ceasing operations in April 2019
(see Figure 1 and 2). At its peak, the market hosted 68,179 drug listings and
2,823 vendors (scraping on 28th March 2019).
The shutdown of Dream Market resulted in a drop in the number listings, from
86,424 listings across markets monitored in final week of monitoring (28th March
2019) versus 22,089 listings across markets in the first week following cessation
(4th April 2019). However, over time, smaller markets such as Empire Market,
Apollon and Cryptonia Market increased in size (see Figure 2). For example, the
average number of listings observed on Cryptonia Market increased by 12.9% in
the month of September 2019 to the month of October 2019 before closure on 14th
November 2019. Apollon hosted 21,282 drug listings on the 23rd July 2019 before
its closure on 28th January 2020, an increase from 4,759 (or 520%) since
monitoring of this market commenced in 26th September 2019. The average
number of listings observed on Apollon increased by 41.1% in the month of
December 2019 to January 2020, with market closure at the end of January.
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In the final week of this monitoring period (24th January 2020 – 31st January 2020),
six marketplaces were monitored. The largest marketplace remaining was Empire
Market (31,620 listings, 1,780 vendors at 23rd January 2020), despite experiencing
prolonged periods of downtime (explaining interpolated data in Figure 2 below),
followed by Dark Market (5,324 listings, 517 vendors on 30th January 2020). This
downtime was due to DDoS (Distributed Denial of Service) attacks.
In total, there was a 12.6% change in the average number of drug listings across
all marketplaces monitored observed in the months of December 2019 versus
January 2020 (48,769 average listings per week from 3 markets versus 54,900
average listings per week from 7 markets, respectively), and -25.2% change in the
average number of drug listings observed in January 2019 (73,434 average
listings per week from 6 markets) versus January 2020.
Note: Complete interactive visualisation available here. Shaded area displays the total number of drug listing
across all markets monitored at a given time. Caveats to this metric are outlined in the methods. Dashed lines
indicate interpolated data over periods where a market could not be monitored. Note that the commencement
and discontinuation of the coloured lines indicates the opening and closure of the named market.
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Market listings captured through cryptomarket monitoring have been categorised
into drug classes according to this methodology.
Cannabis comprised the bulk of the listings identified across all markets over the
total period of monitoring (32.3%), followed by MDMA (12.4%), cocaine (7.7%),
benzodiazepines (7.3%), meth/amphetamine (5.7%) and opioids (excluding heroin;
5.6%) (see Table 1, Figure 3 and Figure 4). As evident from these figures, illicit
substances (e.g., cannabis, MDMA, cocaine, meth/amphetamine) comprised the
majority of substances listed on cryptomarkets. New psychoactive substances
comprised 4.2% of listings, although challenges in their categorisation must be
noted (see methods for further detail).
Note: Complete interactive visualisation available here. Black vertical line indicates last date of monitoring for
Dream Market before closure (28th March 2019). Missing data are interpolated in this figure. See here for
information on how interpolated data were computed.
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In terms of change in the percentage of drug listings across all markets
disaggregated by drug (i.e., the ‘market share’ for each drug), there was <1%
difference in the market share for each drug class across all markets when
comparing the percentage of all listings observed in the months December 2019
and January 2020 (greatest magnitude -0.6% decline in PIEDS1/weight loss drugs
market share).
There was <5% market share percentage change for each drug across all markets
when comparing the percentage of all listings observed in January 2019 and
January 2020 (greatest magnitude -4.9% decline in cannabis market share).
In terms of change in the absolute number of listings per drug across all markets
(i.e., the ‘market size’ for each drug) from the month of January 2019 to January
2020, there were notable declines in some of the larger categories including
PIEDS/weight loss drugs (-43.4% decline in average number of listings to 2,232 in
January 2020) and cannabis (-36.6% decline in average number of listings to
14,964 in January 2020) (see Figure 4 and Table 1).
Note: Black vertical line indicates last date of monitoring for Dream Market before closure (28th March 2019).
Missing data are interpolated in this figure. See here for information on how interpolated data were computed.
MDA, tobacco, paraphernalia, e-cigarettes, PCP, inhalants and alcohol have not been included in the figure.
To view these data see our interactive visualisation.
1PIEDS: performance and image enhancing drugs.
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From the month of December 2019 to January 2020, there was a 121.0% increase
for listings for drug paraphernalia, 68.7% increase in number of listings
categorised as ‘other drugs’ (mostly comprising precursors (e.g., ephedrine) and
drug listings with multiple drugs), and 49.9% increase for hallucinogenic
mushrooms (see Table 1). These findings must be caveated, as these changes
only reflect variation in a small number of listings (i.e., each category <1000
listings per week).
Figure 5 shows the breakdown of listings by drug type per market. These
analyses show that most markets monitored listed an array of different drugs,
although listings for two cannabis markets (CGMC and Cannazon) comprised
>90% cannabis. There was also variability in the market share attributed to each
drug across markets. For example, Dark Bay and Tochka had a greater market
share of opioid listings relative to other markets, while Wall Street had a greater
share of PIEDS/weight loss listings relative to other markets.
Note: See Figure 1 and our interactive timeline for the duration of monitoring each market. This figure displays
drug class percentage of all listings observed from 1st January 2019 to 31st January 2020) for each
marketplace monitored. Missing data are interpolated in this figure. See here for information on how
interpolated data were computed. Cannazon and CGMC are cannabis-specific cryptomarkets.
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Note: Alcohol, e-cigarettes and tobacco and inhalants not shown due to small values. – Per cent suppressed
for values <0.05. All values in table have been calculated using interpolated data. See here for information on
how interpolated data were computed. aThis column displays the percentage of total listings across all
marketplaces observed in the month of January 2020. bThese columns display the change in percentage of
total listings attributed to each drug across all marketplaces in the stated months (e.g., from January in one
year to January in the next year). cThis column displays the average number of weekly listings observed
across all marketplaces in the month of January 2020. d These columns display the the relative change in the
average number of weekly listings observed in the stated months (e.g., from January in one year to January in
the next year).
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Benzodiazepines 7.3 6.6 - -0.2 3601 12.8 -27.3
Cannabis 32.4 27.3 -0.5 -5.0 14964 10.5 -36.6
Cocaine 7.7 8.5 -0.2 0.1 4656 10.0 -24.2
DMT 1.0 1.3 0.1 0.6 729 25.5 36.5
GHB/GBL/1,4-BD 0.4 0.5 - 0.1 249 7.6 9.2
Hallucinogenic 
mushroom
1.1 1.3 0.3 0.2 726 49.9 -11.8
Heroin 2.7 3.0 - 0.5 1660 14.1 -12.1
Ketamine 3.4 4.8 0.4 1.7 2648 22.2 15.7
LSD 4.1 4.8 0.2 0.1 2645 16.6 -6.8
MDA 0.1 0.1 - - 53 16.6 -27.3
MDMA 12.4 14.4 -0.1 0.9 7887 11.8 -20.3
Meth/amphetamine 5.7 6.8 -0.2 0.5 3756 9.0 -18.8
New psychoactive 
substances
4.2 4.5 0.2 0.3 2486 16.7 -22.1
Opioids (excluding 
heroin)
5.6 5.3 0.4 - 2903 20.8 -24.9
Other drugs 0.4 0.6 0.2 0.3 353 68.7 38.6
Other medicines 3.6 3.3 -0.6 -0.1 1802 -4.8 -27.5
Paraphernalia 0.2 0.1 - -0.1 71 121.0 -59.2
PCP - - - - 4 - -
PIEDs/weight loss 4.9 4.1 -0.6 -1.3 2232 -0.8 -43.4
Psychostimulants 
& nootropics
2.6 2.5 0.3 0.4 1388 29.8 -9.4
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• Data visualisations: https://drugtrends.shinyapps.io/cryptomarkets
• Methods document: https://ndarc.med.unsw.edu.au/resource/methods-trends-
cryptomarket-drug-listings
• For more research from the Drug Trends program go to: 
https://ndarc.med.unsw.edu.au/program/drug-trends
Email: drugtrends@unsw.edu.au
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